SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions

Science

Volumn 352, Issue 6282, 2016, Pages 242-246

  Pucci, Ferdinando ^a,d   Garris, Christopher ^a,b   Lai, Charles P ^a,e   Newton, Andita ^a   Pfirschke, Christina ^a   Engblom, Camilla ^a,b   Alvarez, David ^b   Sprachman, Melissa ^a   Evavold, Charles ^a,b   Magnuson, Angela ^a   Von Andrian, Ulrich H ^b   Glatz, Katharina ^c   Breakefield, Xandra O ^a   Mempel, Thorsten R ^a   Weissleder, Ralph ^a   Pittet, Mikael J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d Torque Inc   (United States)

^e NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; IMMUNOGLOBULIN G; PACLITAXEL; TUMOR ANTIGEN; SIALOADHESIN;

CANCER; CELLS AND CELL COMPONENTS; CHEMOTHERAPY; GENETIC ANALYSIS; IMMUNITY; RODENT; TUMOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BIOLUMINESCENCE; BONE MARROW CELL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER STAGING; CELL INTERACTION; EARLY CANCER; EXOSOME; GENETIC ANALYSIS; HORIZONTAL GENE TRANSFER; HOST CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LYMPH NODE CELL; LYMPH VESSEL; MACROPHAGE; MELANOMA; MELANOSOME; MOUSE; NONHUMAN; ONTOGENY; OVERALL SURVIVAL; PRIORITY JOURNAL; SINUS VENOSUS; SUBCAPSULAR SINUS MACROPHAGE; TARGET CELL; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR IMMUNITY; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; CHEMISTRY; EXPERIMENTAL MELANOMA; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPH NODE; PATHOLOGY; SKIN TUMOR; ULTRASTRUCTURE;

MUS;

ANIMALS; B-LYMPHOCYTES; CELL COMMUNICATION; EXTRACELLULAR VESICLES; HUMANS; IMMUNE TOLERANCE; LYMPH NODES; LYMPHATIC VESSELS; MACROPHAGES; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SIALIC ACID BINDING IG-LIKE LECTIN 1; SKIN NEOPLASMS;

EID: 84961390149     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaf1328     Document Type: Article

References (29)

1. D. Hanahan, R. A. Weinberg, Cell 144, 646-674 (2011).
2. S. S. McAllister, R. A. Weinberg, Nat. Cell Biol. 16, 717-727 (2014).
3. M. Colombo, G. Raposo, C. Théry, Annu. Rev. Cell Dev. Biol. 30, 255-289 (2014).
4. H. Peinado et al., Nat. Med. 18, 883-891 (2012).
5. J. Skog et al., Nat. Cell Biol. 10, 1470-1476 (2008).
6. A. Zomer et al., Cell 161, 1046-1057 (2015).
7. F. Pucci, M. J. Pittet, Clin. Cancer Res. 19, 2598-2604 (2013).
8. S. A. Melo et al., Nature 523, 177-182 (2015).
9. H. Shao et al., Nat. Commun. 6, 6999 (2015).
10. C. P. Lai et al., ACS Nano 8, 483-494 (2014).
11. E. E. Gray, J. G. Cyster, J. Innate Immun. 4, 424-436 (2012).
12. A. M. Magnuson et al., Proc. Natl. Acad. Sci. U.S.A. 112, 1511-1516 (2015).
13. H. Yaziji, A. M. Gown, Int. J. Surg. Pathol. 11, 11-15 (2003).
14. H. Stenmark, Nat. Rev. Mol. Cell Biol. 10, 513-525 (2009).
15. M. Gaya et al., Science 347, 667-672 (2015).
16. V. Cortez-Retamozo et al., Proc. Natl. Acad. Sci. U.S.A. 109, 2491-2496 (2012).
17. R. A. Franklin et al., Science 344, 921-925 (2014).
18. M. Iannacone et al., Nature 465, 1079-1083 (2010).
19. W. Kastenmüller, P. Torabi-Parizi, N. Subramanian, T. Lämmermann, R. N. Germain, Cell 150, 1235-1248 (2012).
20. E. A. Moseman et al., Immunity 36, 415-426 (2012).
21. P. Andreu et al., Cancer Cell 17, 121-134 (2010).
22. K. E. de Visser, L. V. Korets, L. M. Coussens, Cancer Cell 7, 411-423 (2005).
23. P. M. Hogarth, G. A. Pietersz, Nat. Rev. Drug Discov. 11, 311-331 (2012).
24. T. A. Wynn, A. Chawla, J. W. Pollard, Nature 496, 445-455 (2013).
25. Y. R. Carrasco, F. D. Batista, Immunity 27, 160-171 (2007).
26. T. Junt et al., Nature 450, 110-114 (2007).
27. T. G. Phan, J. A. Green, E. E. Gray, Y. Xu, J. G. Cyster, Nat. Immunol. 10, 786-793 (2009).
28. C. H. Ries, S. Hoves, M. A. Cannarile, D. Rüttinger, Curr. Opin. Pharmacol. 23, 45-51 (2015).
29. K. Ohnishi et al., Cancer Sci. 104, 1237-1244 (2013).